KRAS and colorectal carcinoma: This response, characterized by the cessation of α-KG export due to the downregulation of SLC25A21, promotes downstream oxidative decarboxylation reactions and GTP production, leading to sustained KRAS activation in KRAS-mutant CRC, which drives cell proliferation.